ROSIGLITAZONE

aa pharma inc🇨🇦 Health Canada

Approval Id: c35b009b80557b6c
Drug Approval Canada Name: ROSIGLITAZONE
Product Name: ROSIGLITAZONE
Status: Marketed
Status Date: 2019-09-17
Original Market Date: 2017-02-21
Din: 02403374
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:20.28
Atc Original: A10BG02 ROSIGLITAZONE
Atc Name: a 10 bg 02
Aig Number: 0138802003
Company Name: aa pharma inc
Company Address: UNIT 1, 1165 Creditstone Road, Vaughan, Ontario, Canada, L4K 4N7

ROSIGLITAZONE (ROSIGLITAZONE MALEATE)

4 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c35b009b80557b6c

Type

Standard